| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:ENPP2-FAM192A |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: ENPP2-FAM192A | FusionPDB ID: 26653 | FusionGDB2.0 ID: 26653 | Hgene | Tgene | Gene symbol | ENPP2 | FAM192A | Gene ID | 5168 | 80011 |
| Gene name | ectonucleotide pyrophosphatase/phosphodiesterase 2 | proteasome activator subunit 3 interacting protein 1 | |
| Synonyms | ATX|ATX-X|AUTOTAXIN|LysoPLD|NPP2|PD-IALPHA|PDNP2 | C16orf94|CDA018|CDA10|FAM192A|NIP30|PIP30 | |
| Cytomap | 8q24.12 | 16q13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ectonucleotide pyrophosphatase/phosphodiesterase family member 2E-NPP 2autotaxin-textracellular lysophospholipase Dphosphodiesterase I/nucleotide pyrophosphatase 2plasma lysophospholipase D | PSME3-interacting proteinNEFA-interacting nuclear protein NIP30PA28G interacting protein 30kDaPA28G-interacting proteinPSME3 interacting protein 30kDafamily with sequence similarity 192 member Aprotein FAM192A | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q13822 | . | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000075322, ENST00000259486, ENST00000427067, ENST00000522167, ENST00000522826, ENST00000518109, | ENST00000562400, ENST00000389447, ENST00000564108, ENST00000566077, ENST00000569266, ENST00000309137, ENST00000567439, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 4 X 2=32 | 21 X 5 X 9=945 |
| # samples | 4 | 21 | |
| ** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(21/945*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: ENPP2 [Title/Abstract] AND FAM192A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ENPP2(120592356)-FAM192A(57188419), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | ENPP2-FAM192A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ENPP2-FAM192A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ENPP2-FAM192A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ENPP2-FAM192A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ENPP2-FAM192A seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. ENPP2-FAM192A seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. ENPP2-FAM192A seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ENPP2 | GO:0009395 | phospholipid catabolic process | 15280042|26371182 |
| Hgene | ENPP2 | GO:0030149 | sphingolipid catabolic process | 14500380 |
| Hgene | ENPP2 | GO:0030334 | regulation of cell migration | 1733949 |
| Hgene | ENPP2 | GO:0034638 | phosphatidylcholine catabolic process | 21240271 |
| Hgene | ENPP2 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 18054784 |
| Fusion gene breakpoints across ENPP2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across FAM192A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | GBM | TCGA-32-1980-01A | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000259486 | ENPP2 | chr8 | 120592356 | - | ENST00000309137 | FAM192A | chr16 | 57188419 | - | 4028 | 1986 | 50 | 2203 | 717 |
| ENST00000259486 | ENPP2 | chr8 | 120592356 | - | ENST00000567439 | FAM192A | chr16 | 57188419 | - | 2294 | 1986 | 50 | 2203 | 717 |
| ENST00000427067 | ENPP2 | chr8 | 120592356 | - | ENST00000309137 | FAM192A | chr16 | 57188419 | - | 3991 | 1949 | 31 | 2166 | 711 |
| ENST00000427067 | ENPP2 | chr8 | 120592356 | - | ENST00000567439 | FAM192A | chr16 | 57188419 | - | 2257 | 1949 | 31 | 2166 | 711 |
| ENST00000522167 | ENPP2 | chr8 | 120592356 | - | ENST00000569266 | FAM192A | chr16 | 57188419 | - | 1134 | 771 | 86 | 988 | 300 |
| ENST00000522826 | ENPP2 | chr8 | 120592356 | - | ENST00000309137 | FAM192A | chr16 | 57188419 | - | 3822 | 1780 | 0 | 1997 | 665 |
| ENST00000522826 | ENPP2 | chr8 | 120592356 | - | ENST00000567439 | FAM192A | chr16 | 57188419 | - | 2088 | 1780 | 0 | 1997 | 665 |
| ENST00000075322 | ENPP2 | chr8 | 120592356 | - | ENST00000309137 | FAM192A | chr16 | 57188419 | - | 3881 | 1839 | 59 | 2056 | 665 |
| ENST00000075322 | ENPP2 | chr8 | 120592356 | - | ENST00000567439 | FAM192A | chr16 | 57188419 | - | 2147 | 1839 | 59 | 2056 | 665 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000259486 | ENST00000309137 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.001109697 | 0.99889034 |
| ENST00000259486 | ENST00000567439 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.002258897 | 0.9977411 |
| ENST00000427067 | ENST00000309137 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.001728671 | 0.99827135 |
| ENST00000427067 | ENST00000567439 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.004051451 | 0.9959486 |
| ENST00000522167 | ENST00000569266 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.000793385 | 0.9992066 |
| ENST00000522826 | ENST00000309137 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.001021643 | 0.9989784 |
| ENST00000522826 | ENST00000567439 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.002050105 | 0.9979499 |
| ENST00000075322 | ENST00000309137 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.001137434 | 0.9988626 |
| ENST00000075322 | ENST00000567439 | ENPP2 | chr8 | 120592356 | - | FAM192A | chr16 | 57188419 | - | 0.002384118 | 0.99761593 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >26653_26653_1_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000075322_FAM192A_chr16_57188419_ENST00000309137_length(amino acids)=665AA_BP=593 MARRSSFQSCQIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPPTVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDF DELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNYQVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMK KGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPESHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVK AGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFSGHKYGPFGPEMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDH GMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVER RWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTF RPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNKLDELNKRLHTKGSTEEPSSCKSLGNTSLSGPSIHCPSAAVCIGILPGLGAYS -------------------------------------------------------------- >26653_26653_2_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000075322_FAM192A_chr16_57188419_ENST00000567439_length(amino acids)=665AA_BP=593 MARRSSFQSCQIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPPTVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDF DELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNYQVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMK KGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPESHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVK AGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFSGHKYGPFGPEMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDH GMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVER RWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTF RPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNKLDELNKRLHTKGSTEEPSSCKSLGNTSLSGPSIHCPSAAVCIGILPGLGAYS -------------------------------------------------------------- >26653_26653_3_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000259486_FAM192A_chr16_57188419_ENST00000309137_length(amino acids)=717AA_BP=645 MARRSSFQSCQIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPPTVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDF DELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNYQVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMK KGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPESHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVK AGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFSGHKYGPFGPEESSYGSPFTPAKRPKRKVAPKRRQERPVAPPKKRRR KIHRMDHYAAETRQDKMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDHGMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFS NNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVERRWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVF VGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTFRPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNK -------------------------------------------------------------- >26653_26653_4_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000259486_FAM192A_chr16_57188419_ENST00000567439_length(amino acids)=717AA_BP=645 MARRSSFQSCQIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPPTVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDF DELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNYQVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMK KGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPESHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVK AGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFSGHKYGPFGPEESSYGSPFTPAKRPKRKVAPKRRQERPVAPPKKRRR KIHRMDHYAAETRQDKMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDHGMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFS NNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVERRWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVF VGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTFRPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNK -------------------------------------------------------------- >26653_26653_5_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000427067_FAM192A_chr16_57188419_ENST00000309137_length(amino acids)=711AA_BP=639 MHWRNPKSKRPVQTRAVRSSRPEHSSQVAGLQPRPRPQRPGRNRRRDSRSMTRHADRIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPP TVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDFDELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNY QVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMKKGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPE SHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVKAGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFS GHKYGPFGPEMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDHGMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYD PKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVERRWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGST FKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTFRPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNKLDELNK -------------------------------------------------------------- >26653_26653_6_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000427067_FAM192A_chr16_57188419_ENST00000567439_length(amino acids)=711AA_BP=639 MHWRNPKSKRPVQTRAVRSSRPEHSSQVAGLQPRPRPQRPGRNRRRDSRSMTRHADRIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPP TVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDFDELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNY QVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMKKGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPE SHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVKAGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFS GHKYGPFGPEMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDHGMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYD PKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVERRWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGST FKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTFRPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNKLDELNK -------------------------------------------------------------- >26653_26653_7_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000522167_FAM192A_chr16_57188419_ENST00000569266_length(amino acids)=300AA_BP=228 MEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVERR WHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTFR PTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKNKLDELNKRLHTKGSTEEPSSCKSLGNTSLSGPSIHCPSAAVCIGILPGLGAYSGSSDS -------------------------------------------------------------- >26653_26653_8_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000522826_FAM192A_chr16_57188419_ENST00000309137_length(amino acids)=665AA_BP=593 MARRSSFQSCQIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPPTVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDF DELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNYQVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMK KGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPESHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVK AGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFSGHKYGPFGPEMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDH GMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVER RWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTF RPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNKLDELNKRLHTKGSTEEPSSCKSLGNTSLSGPSIHCPSAAVCIGILPGLGAYS -------------------------------------------------------------- >26653_26653_9_ENPP2-FAM192A_ENPP2_chr8_120592356_ENST00000522826_FAM192A_chr16_57188419_ENST00000567439_length(amino acids)=665AA_BP=593 MARRSSFQSCQIISLFTFAVGVNICLGFTAHRIKRAEGWEEGPPTVLSDSPWTNISGSCKGRCFELQEAGPPDCRCDNLCKSYTSCCHDF DELCLKTARGWECTKDRCGEVRNEENACHCSEDCLARGDCCTNYQVVCKGESHWVDDDCEEIKAAECPAGFVRPPLIIFSVDGFRASYMK KGSKVMPNIEKLRSCGTHSPYMRPVYPTKTFPNLYTLATGLYPESHGIVGNSMYDPVFDATFHLRGREKFNHRWWGGQPLWITATKQGVK AGTFFWSVVIPHERRILTILQWLTLPDHERPSVYAFYSEQPDFSGHKYGPFGPEMTNPLREIDKIVGQLMDGLKQLKLHRCVNVIFVGDH GMEDVTCDRTEFLSNYLTNVDDITLVPGTLGRIRSKFSNNAKYDPKAIIANLTCKKPDQHFKPYLKQHLPKRLHYANNRRIEDIHLLVER RWHVARKPLDVYKKPSGKCFFQGDHGFDNKVNSMQTVFVGYGSTFKYKTKVPPFENIELYNVMCDLLGLKPAPNNGTHGSLNHLLRTNTF RPTMPEEVTRPNYPGIMYLQSDFDLGCTCDDKVEPKNKLDELNKRLHTKGSTEEPSSCKSLGNTSLSGPSIHCPSAAVCIGILPGLGAYS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:120592356/chr16:57188419) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ENPP2 | . |
| FUNCTION: Hydrolyzes lysophospholipids to produce the signaling molecule lysophosphatidic acid (LPA) in extracellular fluids (PubMed:15769751, PubMed:26371182, PubMed:27754931, PubMed:14500380, PubMed:12354767,). Major substrate is lysophosphatidylcholine (PubMed:12176993, PubMed:27754931, PubMed:14500380). Also can act on sphingosylphosphorylcholine producing sphingosine-1-phosphate, a modulator of cell motility (PubMed:14500380). Can hydrolyze, in vitro, bis-pNPP, to some extent pNP-TMP, and barely ATP (PubMed:15769751, PubMed:12176993). Involved in several motility-related processes such as angiogenesis and neurite outgrowth. Acts as an angiogenic factor by stimulating migration of smooth muscle cells and microtubule formation (PubMed:11559573). Stimulates migration of melanoma cells, probably via a pertussis toxin-sensitive G protein (PubMed:1733949). May have a role in induction of parturition (PubMed:12176993). Possible involvement in cell proliferation and adipose tissue development (Probable). Tumor cell motility-stimulating factor (PubMed:1733949, PubMed:11559573). Required for LPA production in activated platelets, cleaves the sn-1 lysophospholipids to generate sn-1 lysophosphatidic acids containing predominantly 18:2 and 20:4 fatty acids (PubMed:21393252). Shows a preference for the sn-1 to the sn-2 isomer of 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) (PubMed:21393252). {ECO:0000269|PubMed:11559573, ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:12354767, ECO:0000269|PubMed:14500380, ECO:0000269|PubMed:15769751, ECO:0000269|PubMed:1733949, ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:21393252, ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000305|PubMed:15700135}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000075322 | - | 19 | 25 | 55_98 | 593.3333333333334 | 864.0 | Domain | SMB 1 |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000075322 | - | 19 | 25 | 99_143 | 593.3333333333334 | 864.0 | Domain | SMB 2 |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000259486 | - | 20 | 26 | 55_98 | 645.3333333333334 | 916.0 | Domain | SMB 1 |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000259486 | - | 20 | 26 | 99_143 | 645.3333333333334 | 916.0 | Domain | SMB 2 |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000522826 | - | 19 | 26 | 55_98 | 593.3333333333334 | 889.0 | Domain | SMB 1 |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000522826 | - | 19 | 26 | 99_143 | 593.3333333333334 | 889.0 | Domain | SMB 2 |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000075322 | - | 19 | 25 | 127_129 | 593.3333333333334 | 864.0 | Motif | Cell attachment site |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000259486 | - | 20 | 26 | 127_129 | 645.3333333333334 | 916.0 | Motif | Cell attachment site |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000522826 | - | 19 | 26 | 127_129 | 593.3333333333334 | 889.0 | Motif | Cell attachment site |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000075322 | - | 19 | 25 | 211_214 | 593.3333333333334 | 864.0 | Region | Substrate binding |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000075322 | - | 19 | 25 | 244_255 | 593.3333333333334 | 864.0 | Region | Substrate binding |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000259486 | - | 20 | 26 | 211_214 | 645.3333333333334 | 916.0 | Region | Substrate binding |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000259486 | - | 20 | 26 | 244_255 | 645.3333333333334 | 916.0 | Region | Substrate binding |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000522826 | - | 19 | 26 | 211_214 | 593.3333333333334 | 889.0 | Region | Substrate binding |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000522826 | - | 19 | 26 | 244_255 | 593.3333333333334 | 889.0 | Region | Substrate binding |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000075322 | - | 19 | 25 | 830_851 | 593.3333333333334 | 864.0 | Region | Required for secretion |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000259486 | - | 20 | 26 | 830_851 | 645.3333333333334 | 916.0 | Region | Required for secretion |
| Hgene | ENPP2 | chr8:120592356 | chr16:57188419 | ENST00000522826 | - | 19 | 26 | 830_851 | 593.3333333333334 | 889.0 | Region | Required for secretion |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| ENPP2 | |
| FAM192A |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ENPP2-FAM192A |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ENPP2-FAM192A |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies